Is brain imaging overlooking the truth? Research shows that "weak" brain connections predict behavior as well as top signals, ...
On Tuesday, Alto Neuroscience, Inc. (NASDAQ:ANRO) announced an asset purchase agreement with Chase Therapeutics Corporation for a portfolio of dopamine agonist drug combinations for ...
An AI-based machine learning tool identified depression in 71% of people with the condition from under a minute of free speech. The findings may enable more widespread screening for the condition. The ...
A new study found that depression may increase the risk of menstrual pain through factors like sleep disturbances. The findings suggest that treating sleep and mental health issues may help relieve ...
A clinical trial found magnetic seizure therapy (MST) matches electroconvulsive therapy in treating severe depression while ...
Alto Neuroscience Inc. (NYSE:ANRO) is one of the best IPO stocks to buy according to Wall Street analysts. On June 26, Alto Neuroscience announced positive pharmacodynamic results from an exploratory ...
Zacks Investment Research on MSN
Will AbbVie's neuroscience franchise aid top-line growth in Q1?
AbbVie ABBV is set to report first-quarter 2026 results on April 29. While the company’s immunology portfolio will remain the ...
How does the amygdala influence drinking? New research shows sex-specific neural pathways: amygdala reactivity leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results